KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to -$1.2 billion.

  • Eli Lilly's Other Working Capital Changes fell 1242857.14% to -$1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 billion, marking a year-over-year decrease of 3180.5%. This contributed to the annual value of $3.3 billion for FY2024, which is 353.85% down from last year.
  • Per Eli Lilly's latest filing, its Other Working Capital Changes stood at -$1.2 billion for Q3 2025, which was down 1242857.14% from $2.3 billion recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Other Working Capital Changes peaked at $3.6 billion during Q4 2023, and registered a low of -$2.1 billion during Q4 2021.
  • Over the past 5 years, Eli Lilly's median Other Working Capital Changes value was $171.1 million (recorded in 2024), while the average stood at $551.7 million.
  • As far as peak fluctuations go, Eli Lilly's Other Working Capital Changes surged by 94052.29% in 2024, and later tumbled by 1242857.14% in 2025.
  • Over the past 5 years, Eli Lilly's Other Working Capital Changes (Quarter) stood at -$2.1 billion in 2021, then skyrocketed by 178.36% to $1.6 billion in 2022, then surged by 120.83% to $3.6 billion in 2023, then crashed by 95.21% to $171.1 million in 2024, then tumbled by 806.14% to -$1.2 billion in 2025.
  • Its Other Working Capital Changes was -$1.2 billion in Q3 2025, compared to $2.3 billion in Q2 2025 and $3.4 billion in Q1 2025.